M28 Capital Management as of Dec. 31, 2021
Portfolio Holdings for M28 Capital Management
M28 Capital Management holds 12 positions in its portfolio as reported in the December 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Adagio Therapeutics (IVVD) | 32.1 | $41M | 5.7M | 7.26 | |
| Stoke Therapeutics (STOK) | 9.9 | $13M | 527k | 23.99 | |
| Curis Com New | 9.7 | $12M | 2.6M | 4.76 | |
| Wave Life Sciences SHS (WVE) | 9.2 | $12M | 3.8M | 3.14 | |
| Rocket Pharmaceuticals (RCKT) | 8.4 | $11M | 495k | 21.83 | |
| Tg Therapeutics (TGTX) | 7.8 | $10M | 527k | 19.00 | |
| Bridgebio Pharma (BBIO) | 6.1 | $7.8M | 466k | 16.68 | |
| Nektar Therapeutics (NKTR) | 5.9 | $7.6M | 561k | 13.51 | |
| Atara Biotherapeutics (ATRA) | 5.6 | $7.2M | 457k | 15.76 | |
| Leap Therapeutics | 2.5 | $3.2M | 1.0M | 3.24 | |
| Mirati Therapeutics | 2.2 | $2.8M | 19k | 146.67 | |
| Neximmune | 0.5 | $615k | 133k | 4.61 |
